| Prev Close: | 20.25 |
|---|---|
| Open: | N/A |
| Bid: | N/A |
| Ask: | N/A |
| 1y Target Est: | 20.53 |
| Beta: | 1.37 |
| Next Earnings Date: | 31-Jul-13 |
| Day's Range: | N/A - N/A |
|---|---|
| 52wk Range: | 10.85 - 20.75 |
| Volume: | 0 |
| Avg Vol (3m): | 6,483,170 |
| Market Cap: | 5.08B |
| P/E (ttm): | 12.58 |
| EPS (ttm): | 1.61 |
| Div & Yield: | 0.50 (2.60%) |
Quotes delayed, except where indicated otherwise. Currency in USD.
Headlines
- Warner Chilcott Stock Falls On Unusually High Volume (WCRX)at TheStreet(Wed, May 22)
- The Zacks Analyst Blog Highlights: Actavis, Warner Chilcott, Bill Barrett, Linn Energy and Forest OilZacks(Wed, May 22)
- Kasowitz Benson, Eversheds, Latham: Business of Lawat Bloomberg(Wed, May 22)
- After the close: Merck's mysterious gain; Warner and Actavis stay upat MarketWatch(Tue, May 21)
- Actavis Lowers Tax Rate to 17% After Warner Chilcott Dealat Bloomberg(Tue, May 21)
- Actavis to Buy Warner ChilcottZacks(Tue, May 21)
- The Deal: Actavis Extends Gains Following Warner Dealat TheStreet(Tue, May 21)
- 4 Merger and Acquisitions Stock Stories For a Tuesday Appraisalat Wall St. Cheat Sheet(Tue, May 21)
- Warner Chilcott Reaches New 52-Week High (WCRX)at TheStreet(Tue, May 21)
- A Good Deal For Actavis, But Warner Chilcott Goes A Little Cheapat Investopedia(Tue, May 21)
- Actavis: The latest Fortune 500 company to "leave" the U.S. for tax reasonsat Fortune(Tue, May 21)
- Final Trade: Your First Move for Tuesday, May 21at CNBC(Mon, May 20)
- Actavis buying Warner Chilcott in $8.5B dealAP(Mon, May 20)
- Everyone Wins From This Acquisitionat Motley Fool(Mon, May 20)
- Actavis, Warner Chilcott Stocks Rise On Merger Newsat Investor's Business Daily(Mon, May 20)
Press Releases
- Announcement Under Irish Takeover Rules Revision to Relevant Securities in IssueGlobeNewswire(Mon, May 20)
- Actavis to Acquire Warner Chilcott to Create Premier $11 Billion Revenue Global Specialty Pharmaceutical CompanyPR Newswire(Mon, May 20)
- Announcement Under Irish Takeover Rules Relevant Securities in IssueGlobeNewswire(Mon, May 13)
Reports
- WCRX - Warner Chilcott Plc - Upgraded to a Buy - Company Analysis and ASR Ranking...Alpha Street Research(May 24)
- ValuEngine Industry Report for Medical-drugsValuEngine, Inc.(May 22)
- WCRX: Due Diligence Review: Forensic Earnings and ValuationNew Constructs, LLC(May 20)